Finance

Lists
4521:TYO
Kaken Pharmaceutical Co Ltd
3 705,00 JP¥
0,00%
(0,00) 1D
9-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4521...
Mkt. cap
163,54 млд
Avg. vol.
109,69 миң
Volume
0,00
Dividend
5,13%
Quarterly dividend
48 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
13,61
52-wk high
4 445 JP¥
52-wk low
3 540 JP¥
EPS
272 JP¥
Shares outstanding
39,72 млн
No. of employees
1 миң
Mkt. cap
163,54 млд
Avg. vol.
109,69 миң
Volume
0,00
Dividend
5,13%
Quarterly dividend
48 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
13,61
52-wk high
4 445 JP¥
52-wk low
3 540 JP¥
EPS
272 JP¥
Shares outstanding
39,72 млн
No. of employees
1 миң
News stories
From web sources and news partners
About Kaken Pharmaceutical Co Ltd
CEO-
Employees1,11 миң
Founded1917
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 7-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
30,16 млд / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
20,49 млд
18,26 млд
19,25 млд
30,16 млд
Cost of goods sold
8,78 млд
9,01 млд
10,09 млд
9,18 млд
Cost of revenue
8,78 млд
9,01 млд
10,09 млд
9,18 млд
Research and development expenses
6,29 млд
3,97 млд
4,94 млд
4,60 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,23 млд
4,92 млд
4,92 млд
5,47 млд
Operating expense
11,52 млд
8,90 млд
10,62 млд
10,07 млд
Total operating expenses
20,30 млд
17,91 млд
20,71 млд
19,25 млд
Operating income
187,00 млн
354,00 млн
-1,46 млд
10,90 млд
Other non operating income
-27,00 млн
34,00 млн
43,00 млн
8,00 млн
EBT including unusual items
988,00 млн
588,00 млн
328,00 млн
11,24 млд
EBT excluding unusual items
184,00 млн
598,00 млн
-1,41 млд
11,26 млд
Income tax expense
267,00 млн
182,00 млн
-418,00 млн
2,80 млд
Effective tax rate
27,02%
-
-127,44%
24,93%
Other operating expenses
-
-
-
-
Net income
721,00 млн
406,00 млн
746,00 млн
8,44 млд
Net profit margin
3,52%
-
3,87%
27,99%
Earnings per share
-
-
-
-
Interest and investment income
78,00 млн
324,00 млн
91,00 млн
393,00 млн
Interest expense
-11,00 млн
-11,00 млн
-13,00 млн
-14,00 млн
Net interest expenses
67,00 млн
313,00 млн
78,00 млн
379,00 млн
Depreciation and amortization charges
-
-
752,00 млн
-
EBITDA
922,00 млн
992,50 млн
-624,75 млн
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору